JamesIGellerMD

Pediatric Hematology & Oncology • San Diego, CA

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Geller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Geller's full profile

Already have an account?

Office
3010 Childrens Way
San Diego, CA 92123
Phone+1 858-966-5811

Fax+1 513-636-3549

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2000 - 2004
Westchester Medical CenterResidency, Pediatrics, 1997 - 2000
Tel Aviv University SacklerClass of 1997

Certifications & Licensure

CA State Medical License 2024 - 2027
OH State Medical License 2004 - 2027
KY State Medical License 2021 - 2025
NC State Medical License 2020 - 2022
TN State Medical License 2000 - 2006
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Start of enrollment: 2010 Mar 01
Completed
Phase 1
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma Start of enrollment: 2010 May 01
Withdrawn
Not Applicable
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Start of enrollment: 2010 Aug 01
Completed
Phase 1
A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma Start of enrollment: 2011 Oct 01
Terminated
Early Phase 1
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) Start of enrollment: 2019 Jan 08
Active, not recruiting
Phase 2
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative Start of enrollment: 2018 Aug 12
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Start of enrollment: 2020 Oct 19
Recruiting
Phase 2
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma Start of enrollment: 2020 Nov 01
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321.
James I Geller, Lindsay A Renfro, Paul E Grundy, Elizabeth J Perlman, John A Kalapurakal
Pediatric Blood & Cancer. 2025-03-01
Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation.
Ashton D Hall, Hope A Hendricks, Katherine A Bowers, James I Geller, Alexander J Bondoc
Pediatric Transplantation. 2025-02-01
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Daniela Perotti, Maureen J O'Sullivan, Amy L Walz, Jonathan Davick, Reem Al-Saadi
Nature Reviews. Urology. 2025-01-29

Lectures

A prospective study of pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN0321.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

First-Ever Prospective Trial in Pediatric RCC Reports ResultsOctober 21st, 2020
Translocation Renal Cell Carcinoma (tRCC) Research InitiativeJune 24th, 2019
Calgary Family Turns to Cincinnati for Liver Transplant for Cancer-Stricken DaughterApril 28th, 2017
Join now to see all